Keros Therapeutics reported total assets of $287.60M and total liabilities of $25.28M for the quarter ended Jun 2026, down 63.3% year over year. This balance sheet covers 29 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 237.11M | 221.35M | 230.04M | 228.59M | 215.62M | 239.43M | 279.05M | 351.43M | 322.03M | 287.89M | 331.15M | 442.44M | 405.86M | 530.68M | 559.93M | 720.54M | 690.22M | 693.47M | 287.42M | 257.61M | |||||||||
| Cash & Current Investments | 237.11M | 221.35M | 230.04M | 228.59M | 215.62M | 239.43M | 279.05M | 351.43M | 322.03M | 287.89M | 331.15M | 442.44M | 405.86M | 530.68M | 559.93M | 720.54M | 690.22M | 693.47M | 287.42M | 257.61M | |||||||||
| Receivables - NetNet Receivables | 0.10M | 18.00M | 0.14M | 0.23M | 0.00M | 0.39M | 2.74M | 17.29M | 15.82M | 3.49M | 3.57M | ||||||||||||||||||
| Receivables - OtherOther Receivables | |||||||||||||||||||||||||||||
| Receivables | 0.10M | 18.00M | 0.14M | 0.23M | 0.00M | 0.39M | 2.74M | 17.29M | 15.82M | 3.49M | 3.57M | ||||||||||||||||||
| Prepaid Assets | 4.20M | 4.72M | 3.40M | 2.63M | 6.74M | 6.45M | 6.72M | 10.79M | 12.28M | 16.54M | 16.00M | 20.46M | 26.85M | 20.97M | 26.22M | 21.68M | 26.78M | 22.34M | 22.20M | 7.03M | |||||||||
| Current Assets | 241.42M | 226.07M | 251.44M | 231.22M | 222.36M | 245.88M | 285.77M | 362.22M | 334.31M | 304.44M | 347.29M | 463.13M | 432.71M | 552.05M | 588.89M | 759.51M | 732.81M | 719.31M | 315.43M | 266.88M | |||||||||
| Non-Current Assets | |||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 1.25M | 1.29M | 1.33M | 1.46M | 1.65M | 1.68M | 2.02M | 2.93M | 3.09M | 3.36M | 4.13M | 4.43M | 4.29M | 4.37M | 4.24M | 4.47M | 4.84M | 4.56M | 4.30M | 3.71M | |||||||||
| Other Non-Current Assets | 0.12M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 1.21M | 2.05M | 1.21M | 1.21M | 1.45M | 2.06M | 1.45M | 1.45M | 1.45M | 1.45M | 1.45M | |||||||||
| Non-Current Assets | 2.04M | 3.89M | 3.81M | 3.92M | 4.30M | 6.67M | 21.01M | 22.21M | 22.00M | 21.81M | 22.73M | 22.69M | 22.31M | 27.23M | 26.99M | 25.05M | 24.36M | 23.48M | 22.59M | 20.72M | |||||||||
| Assets | 243.46M | 229.96M | 255.25M | 235.14M | 226.66M | 252.55M | 306.78M | 384.44M | 356.31M | 326.25M | 370.02M | 485.82M | 455.02M | 579.27M | 615.89M | 784.56M | 757.16M | 742.78M | 338.02M | 287.60M | |||||||||
| Liabilities | |||||||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||||||
| Accounts Payables | 1.37M | 2.81M | 3.65M | 3.06M | 7.66M | 2.65M | 3.34M | 4.68M | 4.15M | 3.87M | 5.45M | 4.99M | 6.54M | 4.98M | 4.60M | 6.64M | 5.27M | 2.30M | 1.97M | 1.82M | |||||||||
| Payables | 1.37M | 2.81M | 3.65M | 3.06M | 7.66M | 2.65M | 3.34M | 4.68M | 4.15M | 3.87M | 5.45M | 4.99M | 6.54M | 4.98M | 4.60M | 6.64M | 5.27M | 2.30M | 1.97M | 1.82M | |||||||||
| Accumulated Expenses | 5.71M | 7.36M | 7.34M | 7.70M | 7.12M | 8.41M | 12.75M | 10.78M | 11.95M | 12.22M | 17.92M | 12.68M | 13.61M | 22.17M | 20.87M | 17.29M | 19.96M | 15.17M | 16.04M | 7.74M | |||||||||
| Current Leases | 0.45M | 0.84M | 0.86M | 0.88M | 0.67M | 0.46M | 0.46M | 0.61M | 1.00M | 1.05M | 1.10M | 1.86M | 1.98M | 2.10M | 2.23M | 2.32M | 2.41M | 2.60M | |||||||||||
| Current Taxes | 10.04M | 6.32M | 4.15M | ||||||||||||||||||||||||||
| Current Deferred Revenue | 3.31M | 0.93M | 0.15M | ||||||||||||||||||||||||||
| Total Current Liabilities | 7.53M | 11.02M | 11.85M | 11.65M | 15.45M | 11.53M | 16.55M | 15.46M | 16.09M | 16.70M | 24.37M | 18.72M | 21.25M | 29.01M | 27.45M | 39.38M | 34.71M | 24.09M | 20.41M | 12.15M | |||||||||
| Non-Current Liabilities | |||||||||||||||||||||||||||||
| Preferred Stock Liabilities | |||||||||||||||||||||||||||||
| Operating Leases | 0.24M | 1.30M | 0.23M | 12.81M | 13.99M | 13.95M | 14.31M | 13.44M | 13.15M | 12.86M | 19.29M | 16.88M | 16.31M | 15.72M | 15.11M | 14.47M | 13.13M | ||||||||||||
| Other Non-Current Liabilities | 0.03M | 0.02M | |||||||||||||||||||||||||||
| Total Non-Current Liabilities | 7.77M | 11.47M | 12.08M | ||||||||||||||||||||||||||
| Total Liabilities | 7.80M | 11.48M | 12.08M | 11.65M | 15.45M | 11.53M | 29.36M | 29.45M | 30.05M | 30.41M | 37.81M | 31.87M | 34.11M | 46.44M | 44.33M | 55.69M | 50.43M | 39.20M | 34.89M | 25.28M | |||||||||
| Shareholder's Equity | |||||||||||||||||||||||||||||
| Common Equity | 235.66M | 218.48M | 243.17M | 223.49M | 211.21M | 241.03M | 277.42M | 354.98M | 326.26M | 295.84M | 332.21M | 453.95M | 420.92M | 532.84M | 571.55M | 728.87M | 706.73M | 703.58M | 303.13M | 262.32M | |||||||||
| Liabilities and Shareholders Equity | 243.46M | 229.96M | 255.25M | 235.14M | 226.66M | 252.55M | 306.78M | 384.44M | 356.31M | 326.25M | 370.02M | 485.82M | 455.02M | 579.27M | 615.89M | 784.56M | 757.16M | 742.78M | 338.02M | 287.60M | |||||||||
| Treasury Shares | 21.13M | 21.13M | |||||||||||||||||||||||||||
| Retained Earnings | 332.17M | 335.29M | 366.93M | 371.43M | 386.41M | 439.74M | 505.86M | 619.22M | 628.00M | 637.02M | 713.64M | 878.48M | 890.71M | 1,055.58M | 1,140.33M | 1,149.19M | 1,157.75M | 1,161.88M | 1,169.45M | 1,181.06M |